Related Experiment Video

Updated: Mar 28, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

7.9K

Association between microbial characteristics and poor outcomes among patients with methicillin-resistant

Jennifer S McDanel1, Eli N Perencevich1, Daniel J Diekema2

  • 1Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA USA ; Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA USA ; Iowa City Veterans Affairs Health Care System, Iowa City, IA USA.

Antimicrobial Resistance and Infection Control
|December 16, 2015
PubMed
Abstract

Insights

Microbial characteristics did not predict outcomes in methicillin-resistant Staphylococcus aureus (MRSA) pneumonia patients. Further research is needed to understand MRSA pneumonia

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Microbiology

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) pneumonia is linked to adverse clinical outcomes.
  • Understanding factors influencing MRSA pneumonia prognosis is crucial for patient management.

Purpose of the Study:

  • To investigate the association between specific microbial characteristics and poor outcomes in patients diagnosed with MRSA pneumonia.
  • To identify potential predictors of mortality and prolonged hospital stays in MRSA pneumonia cases.

Main Methods:

  • A retrospective cohort study involving 75 patients with MRSA pneumonia.
  • Utilized Cox proportional hazards and ordinal logistic regression models for multivariable analysis.
  • Adjusted for clinical and demographic factors including comorbidities and antibiotic treatment.

Main Results:

  • No significant association was found between microbial characteristics (PFGE type, agr dysfunction, SCCmec type, PVL, ACME, TSST-1) and 30-day mortality.
  • Microbial factors did not significantly predict increased length of hospital stay post-infection.
  • Clinical and demographic factors, not microbial traits, were considered in the multivariable models.

Conclusions:

  • Current microbial typing and toxin detection methods did not reveal significant associations with MRSA pneumonia outcomes in this cohort.
  • Larger, prospective studies are recommended to further elucidate the impact of microbial virulence factors on MRSA pneumonia prognosis.
  • The findings underscore the need for continued investigation into the complex interplay of host, pathogen, and treatment in MRSA pneumonia.
Keywords:
Accessory Gene RegulatorMRSA pneumoniaPanton-Valentine leukocidinlength of staymortality

More Related Videos

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

1.3K
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

23.8K

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
29
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
95
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
37
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
46
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
18